SK-MEL-29.1 Cells
USUSD$800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | SK-MEL-29.1 is a melanoma cell line that has been extensively studied for its interactions with the immune system, particularly in the context of cytotoxic T-lymphocyte (CTL) recognition. This subclone of the SK-MEL-29 melanoma line has been used in immunological research to define specific antigens recognized by autologous CTLs. These CTLs selectively target melanoma cells expressing certain antigens, while sparing non-cancerous cells. In immunoselection experiments, SK-MEL-29.1 was found to express stable antigens that are important for the specific lysis of melanoma cells by CTLs, providing insights into tumor immunogenicity and immune evasion. One of the key studies involving SK-MEL-29.1 demonstrated its utility in cancer immunotherapy research. CTL clones derived from patient AV were shown to effectively target SK-MEL-29.1 cells, which express multiple antigens simultaneously. This makes SK-MEL-29.1 an important model for understanding how immune responses can be tailored to target specific antigens in melanoma. The ability of these CTL clones to identify and lyse melanoma cells provides valuable information for the development of immunotherapeutic strategies, including the possibility of generating personalized cancer vaccines. Furthermore, SK-MEL-29.1 cells have also been tested in virus-based cancer vaccine development. Infection with the Newcastle disease virus (NDV), a virus with oncolytic and immune-stimulatory properties, demonstrated that SK-MEL-29.1 can be efficiently infected by NDV even after gamma-irradiation, making it a suitable candidate for the development of live cancer vaccines. This infection enhances the immunogenicity of the tumor cells, leading to a more robust anti-tumor immune response, further supporting the use of SK-MEL-29.1 in vaccine research. |
|---|---|
| 生物體 | Human |
| 組織 | Skin |
| 疾病 | Melanoma |
特徵
| 年齡 | 19 years |
|---|---|
| 性別 | Male |
| 形態學 | Epithelial |
| 生長特性 | Adherent |
監管數據
| 引用 | SK-MEL-29.1 (Cytion catalog number 300429) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_IY54 |
生物分子資料
處理方式
| 培養基 | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% FBS |
| 解離試劑 | Accutase |
| 傳代培養 | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 300429-091023 | 分析證明書 | 23. May. 2025 | 300429 |